PHARMASEQ, INC.

Basic Information

PHARMASEQ, INC.
MONMOUTH JUNCTION, NJ, 08852-1923

Company Profile

PharmaSeq, Inc. has developed and patented an ultra-small microtransponder tag (a "p-Chip®") that will revolutionize several billion-dollar industries. The p-Chip is the smallest, most technologically-advanced commercial product available today for tagging and authenticating consumer goods, industrial goods and small animals. The p-Chip also has many applications in bioassays, including in vitro diagnostics, drug discovery and combinatorial synthesis of nucleic acids and proteins. It is at least 100 times smaller than the current gold standard RFID tags and is inexpensive to manufacture in volume. The p-Chip is nearly impossible to counterfeit and can be used reliably in environmentally-challenging conditions.

Additional Details

Field Value
DUNS: 27661870
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 14


  1. Sequenece-specific detection of proteases using electronic p-Chips in multiplex format

    Amount: $224,965.00

    DESCRIPTION provided by applicant The main goal of this project is to demonstrate the feasibility of combining novel cancer testing using F rster resonance energy transfer FRET with an emerging p ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  2. Genome-scale De Novo DNA Synthesis on Electronic p-Chips with Sorting

    Amount: $286,085.00

    DESCRIPTION provided by applicant The purpose of the present project is to develop and validate a new method for synthesizing large number of DNA fragments oligodeoxynucleotides The method which ...

    SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
  3. SBIR Phase II: A microscopic electronic chip with sensors that can be implanted into living cells to monitor events in real time

    Amount: $659,188.00

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to provide researchers and educators a powerful device to monitor biochemical reactio ...

    SBIR Phase II 2015 National Science Foundation
  4. HHSN261201400050C;TOPIC 309?DEVELOPMENT OF LOW COST, SMALL SAMPLE MULTI-ANALYTE TECH. FOR CANCER DIAGNOSIS,PROGNOSISandEARLY DETECTION?;TITLE:HIGHLY SENSITIVE AND SPECIFIC MULTIPLEX PROSTATE CANCER ASSA

    Amount: $998,411.00

    Not Available

    SBIR Phase II 2014 Department of Health and Human Services
  5. Light-activated Electronic p-Chips for Tagging Samples in Biorepositories and Cry

    Amount: $911,270.00

    DESCRIPTION (provided by applicant): The purpose of the present project is to implement a new RFID tagging system for rapid identification of vials in biorepositories. It is based on the PharmaSeq las ...

    SBIR Phase II 2013 Department of Health and Human Services
  6. SBIR Phase I: A Radio p-Chip for intracellular sensing and communication

    Amount: $149,989.00

    This Small Business Innovation Research (SBIR) Phase I project aims at developing a Radio p-Chip, the first microchip with a sensor that can be injected into live cells, and transmit information from ...

    SBIR Phase I 2013 National Science Foundation
  7. Tagging of Histopathology Specimens with Light-Activated RFID p-Chips

    Amount: $1,172,636.00

    DESCRIPTION (provided by applicant): The purpose of the present project is to develop and validate the use of ultra-small RFID chips to tag and track tissue cassettes and glass slides that are used in ...

    SBIR Phase II 2012 Department of Health and Human Services
  8. Characterization of antitumor auto-antibodies using combinatorial peptide librari

    Amount: $272,360.00

    DESCRIPTION (provided by applicant): The development of circulating auto-antibodies to tumor-associated antigens (TAAs) has been observed at early cancer stages. TAA auto-antibodies are attractive as ...

    SBIR Phase I 2012 Department of Health and Human Services
  9. Light-activated Electronic p-Chips for Tagging Samples in Biorepositories and Cry

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): The purpose of the present project is to implement a new RFID tagging system for rapid identification of vials in biorepositories. It is based on the PharmaSeq las ...

    SBIR Phase I 2012 Department of Health and Human Services
  10. IGF::OT::IGF OTHER FUNCTIONS PHARMASEQ PHASE I, TOPIC 309, MULTIPLEX PROSTATE CANCER SERUM ASSAY ON RFID P-CHIPS

    Amount: $199,909.00

    The project is aimed at the development of a cost effective, serum-based multiplex assay for early detection of clinically significant forms of prostate cancer. The assay utilizes metal-enhanced flour ...

    SBIR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government